Results in late-stage testing of Sinovac shot were almost 30 percentage points lower than previously announced, as concerns grow over the study’s transparency.
Results in late-stage testing of Sinovac shot were almost 30 percentage points lower than previously announced, as concerns grow over the study’s transparency.